Clinical Trial

AI-assisted Diagnosis of Malignant Brain Tumors

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 30, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to establish a large-scale, multi-center MRI database for malignant brain tumors. It will develop an artificial intelligence system for the segmentation and classification of multiple subtypes of brain tumors (including glioma, metastatic tumor and lymphoma et al.) using deep learning technology. This will address the issues of small sample sizes and limited classification performance in existing methods, thereby improving the accuracy of non-invasive preoperative diagnosis, reducing the need for biopsies, and having significant clinical translational value.
Protocol Amendment History 1 change
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
Trial Details
NCT Number NCT07198256
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators: Zhejiang Cancer Hospital
Conditions Gliomas, Brain Metastases, Adult, Lymphoma, Brain Tumor Adult
Enrollment 3,000 participants
Start Date 2025-09-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-30